15 December 2020
Issues of New Ordinary Shares in Connection with the Byfavo™ Acquisition
15 December 2020
Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™
14 August 2020
Proposed Capital Raising
14 August 2020
Results of Placing
13 August 2020
Acacia Pharma Group plc - Proposed Capital Raising by way of a Placing of New Ordinary Shares
13 August 2020
Interim Results for the Six Months ended 30 June 2020
24 March 2020
Acacia Pharma Prospectus: Issues of New Ordinary Shares in connection with the BYFAVO™ Acquisition
02 March 2020
Results for the Year ended 31 December 2019
27 February 2020
Acacia Pharma Announces US FDA Approval of BARHEMSYS® (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting (PONV)
24 January 2020
Acacia Pharma Wins BEL Small Company of the Year 2019
13 January 2020
Acacia Pharma Announces Planned CFO Succession
10 January 2020
Acacia Pharma Enters into Strategic In-licensing, Investment and Loan Transaction with Cosmo Pharmaceuticals N.V.
American Society for Metabolic & Bariatric Surgery (ASMBS)
Las Vegas, NV
3-7 November 2019